Walleye Trading’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,137
Closed -$585K 4658
2025
Q3
$585K Buy
+1,137
New +$496K ﹤0.01% 2635
2024
Q1
Sell
-278
Closed -$97.7K 5103
2023
Q4
$85.2K Sell
278
-44
-14% -$11.9K ﹤0.01% 4204
2023
Q3
$78K Buy
+322
New +$82.4K ﹤0.01% 4073
2023
Q1
Sell
-1,016
Closed -$210K 5165
2022
Q4
$216K Buy
+1,016
New +$203K ﹤0.01% 3516
2021
Q1
Sell
-128
Closed -$19.6K 5097
2020
Q4
$18K Buy
+128
New +$16.1K ﹤0.01% 4389
2020
Q2
Sell
-741
Closed -$63.1K 4462
2020
Q1
$54K Buy
+741
New +$64.3K ﹤0.01% 3399
2018
Q4
Sell
-320
Closed -$19K 5037
2018
Q3
$19K Buy
+320
New +$17.5K ﹤0.01% 4853
2017
Q2
Sell
-12,800
Closed -$382K 4765
2017
Q1
$382K Buy
12,800
+2,100
+20% +$67.8K ﹤0.01% 2468
2016
Q4
$386K Buy
+10,700
New +$356K ﹤0.01% 2296

Other funds holding MEDP

Walleye Trading's MEDP Position: Q4 2025 in Review

Walleye Trading sold out of Medpace (MEDP) in Q4 2025, closing a stake of 1,137 shares — an estimated $585K sold.

Walleye Trading first reported a position in MEDP in Q4 2016 and held it in 9 quarters. The position peaked at $585K in Q3 2025. 787 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Walleye Trading reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 1,137 Medpace shares in Q4 2025, an estimated $585K.
  • Walleye Trading first reported a position in Medpace in Q4 2016 and held it in 9 quarters.
  • Walleye Trading's Medpace position peaked at $585K in Q3 2025.
  • 787 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.